--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
Vale SA
VALE
Coinbase
COIN
US Stock MarketDetailed Quotes
GRCE Grace Therapeutics
- 3.900
- -0.035-0.89%
Close Jan 24 16:00 ET
- 3.800
- -0.100-2.56%
Post 19:45 ET
39.55MMarket Cap-4.29P/E (TTM)
3.990High3.839Low78.10KVolume3.990Open3.935Pre Close304.44KTurnover1.68%Turnover RatioLossP/E (Static)10.14MShares4.96552wk High0.70P/B18.12MFloat Cap2.12652wk Low--Dividend TTM4.65MShs Float2016.000Historical High--Div YieldTTM3.83%Amplitude1.720Historical Low3.898Avg Price1Lot Size
Grace Therapeutics Key Stats
Grace Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Grace Therapeutics Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data